Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma

Bergh, 1989, Measurement of complement activation in rabbit plasma and serum using monoclonal antibodies against C5a, Scand. J. Immunol., 29, 333, 10.1111/j.1365-3083.1989.tb01132.x Bergh, 1988, Monoclonal antibodies against the major zymosan-induced chemotactic factor in rabbit serum, J. Immunol. Methods, 108, 179, 10.1016/0022-1759(88)90417-6 Bergh, 1991, Complement activation and pulmonary dysfunction in experimental Escherichia coli septicemia, Acta Anaesthesiol. Scand., 35, 267, 10.1111/j.1399-6576.1991.tb03286.x Bhakdi, 1988, Relative inefficiency of terminal complement activation, J. Immunol., 141, 3117, 10.4049/jimmunol.141.9.3117 Bokisch, 1970, Anaphylatoxin inactivator of human plasma. Its isolation and characterization as a carboxypeptidase, J. Clin. Invest., 49, 2427, 10.1172/JCI106462 Bøyum, 1968, Isolation of mononuclear cells and granulocytes from human blood, Scand. J. Clin. Lab. Invest., 21, 77 Engvall, 1980, Enzyme immunoassay ELISA and EMIT, Vol. 70, 419 Fernandez, 1978, Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluations of C3a and C5a leukotaxis in vivo and in vitro, J. Immunol., 120, 109, 10.4049/jimmunol.120.1.109 Gerard, 1989, Characterization of a receptor for C5a anaphylatoxin on human eosinophils, J. Biol. Chem., 264, 1760, 10.1016/S0021-9258(18)94252-3 Hammerschmidt, 1980, Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome, Lancet, i, 947, 10.1016/S0140-6736(80)91403-8 Huey, 1985, Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN), J. Immunol., 135, 2063, 10.4049/jimmunol.135.3.2063 Hugli, 1984, Structure and function of the anaphylatoxins, Springer Semin. Immunopathol., 7, 193, 10.1007/BF01893020 Hugli, 1978, Anaphylatoxins: C3a and C5a, Adv. Immunol., 26, 1, 10.1016/S0065-2776(08)60228-X Jørstad, 1987, Biocompatibility of different hemodialysis and plasmapheresis membranes, Blood Purif., 5, 123, 10.1159/000169462 Klos, 1988, Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies, J. Immunol. Methods, 111, 241, 10.1016/0022-1759(88)90133-0 Mollnes, 1988, Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation, Clin. Exp. Immunol., 73, 484 Mollnes, 1991, Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin, Ann. Thorac. Surg., 52, 92, 10.1016/0003-4975(91)91426-V Nelson, 1975, Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes, J. Immunol., 115, 1650, 10.4049/jimmunol.115.6.1650 Oi, 1980, Immunoglobulin-producing hybrid cell lines, 351 Olson, 1985, The role of C5 in septic lung injury, Ann. Surg., 202, 771, 10.1097/00000658-198512000-00018 Oppermann, 1991, A sensitive immunoassay for the quantitation of human C5a/C5a(des Arg) anaphylatoxin using a monoclonal antibody with specificity for a neopepitope, Complement Inflamm., 8, 13, 10.1159/000463173 Rollins, 1985, Identification of the polymorphonuclear leukocyte C5a receptor, J. Biol. Chem., 260, 7157, 10.1016/S0021-9258(17)39585-6 Rollins, 1991, Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex, 88, 971 Snyderman, 1970, Polymorphonuclear leukocyte chemotactic activity in rabbit serum and guinea pig serum treated with immune complexes: Evidence for C5a as the major chemotactic factor, Infect. Immun., 1, 521, 10.1128/IAI.1.6.521-525.1970 Stähli, 1983, Distinction of epitopes by monoclonal antibodies, Methods Enzymol., 92, 242, 10.1016/0076-6879(83)92023-2 Stevens, 1986, Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates, J. Clin. Invest., 77, 1812, 10.1172/JCI112506 Takeda, 1987, Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies, J. Immunol. Methods, 101, 265, 10.1016/0022-1759(87)90159-1 Wagner, 1984, Radioimmunoassay for anaphylatoxins: A sensitive method for determining complement activation products in biological fluids, Anal. Biochem., 136, 75, 10.1016/0003-2697(84)90308-7 Webster, 1982, In vivo clearance and tissue distribution of C5a and C5a des argnine complement fragments in rabbits, J. Clin. Invest., 70, 1177, 10.1172/JCI110716